GenMont Biotech Incorporation (TPE:3164)

Market Cap	1.45B -10.2%
Revenue (ttm)	382.11M -1.1%
Net Income	69.17M +344.7%
EPS	0.80 +345.5%
Shares Out	86.01M
PE Ratio	21.10
Forward PE	n/a
Dividend	0.80 (4.73%)
Ex-Dividend Date	Apr 8, 2026

Volume	339,328
Open	16.90
Previous Close	16.90
Day's Range	16.90 - 17.20
52-Week Range	15.35 - 19.75
Beta	0.06
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3164

Financial Performance

In 2025, TPE:3164's revenue was 401.23 million, an increase of 4.11% compared to the previous year's 385.37 million. Earnings were 57.20 million, a decrease of -0.09%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error